Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alpha Tau Medical Ltd. (DRTS)

9.205   -1.415 (-13.32%) 08-18 07:28
Open: 10.25 Pre. Close: 10.62
High: 10.5 Low: 9.0021
Volume: 39,582 Market Cap: 630(M)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.51 - 10.58 10.58 - 10.62
Low: 8.86 - 8.94 8.94 - 8.99
Close: 9.11 - 9.22 9.22 - 9.29

Technical analysis

as of: 2022-08-17 4:22:45 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 12.28     One year: 13.37
Support: Support1: 9    Support2: 7.48
Resistance: Resistance1: 10.51    Resistance2: 11.44
Pivot: 10.59
Moving Average: MA(5): 10.34     MA(20): 10.62
MA(100): 9.55     MA(250): 9.9
MACD: MACD(12,26): -0.1     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 25.8     %D(3): 27.7
RSI: RSI(14): 35.5
52-week: High: 20.64  Low: 4.68
Average Vol(K): 3-Month: 104 (K)  10-Days: 19 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ DRTS ] has closed below the lower bollinger band by 33.2%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ DRTS ] is to continue within current trading range. It is unclear right now based on current values. 60.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 18 Aug 2022
DRT Strategies CEO James Gordon Presented 1st Wash100 Award By Executive Mosaic CEO Jim Garrettson - GovCon Wire

Wed, 17 Aug 2022
DRT chapter hosts Texas essay contest - Fredericksburg Standard

Tue, 16 Aug 2022
FCT moves resuscitates Abuja urban mass transport company – The Sun Nigeria - Daily Sun

Mon, 15 Aug 2022
Insiders might want to re-evaluate their US$724k stock purchase as DIRTT Environmental Solutions Ltd. (TSE:DRT) drops to CA$78m - Yahoo Finance

Fri, 12 Aug 2022
All aboard! How on‑demand public transport is getting back on the road - The Guardian

Thu, 11 Aug 2022
Alpha Tau Medical (NASDAQ:DRTS) Trading 0.4% Higher - Defense World

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 68 (M)
Shares Float 38 (M)
% Held by Insiders 34.6 (%)
% Held by Institutions 3.9 (%)
Shares Short 262 (K)
Shares Short P.Month 201 (K)

Stock Financials

EPS -0.99
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.39
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) -57.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.28
Qtrly Earnings Growth 0
Operating Cash Flow -15 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -9.4
PEG Ratio 0
Price to Book value 6.57
Price to Sales 0
Price to Cash Flow -41.29

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.